Randomized clinical trial of adjuvant chemotherapy with docetaxel and carboplatin for completely resected stage IB to IIIA non-small cell lung cancer (NSCLC): Preliminary result of Chinese society of lung cancer (CSLC) protocol 0201

被引:0
|
作者
Yang, X
Wu, Y
Chen, G
Xu, L
Gu, L
Tang, P
Zhu, Y
Xiao, P
Tang, J
Xie, L
机构
[1] Guangdong Provincial Peoples Hosp, Ctr Canc, Guangzhou, Peoples R China
[2] Guangdong Provincial Peoples Hosp, Lung Canc Res Inst, Guangzhou, Peoples R China
[3] Zhongshan Univ, 3rd Hosp, Guangzhou, Guangdong, Peoples R China
关键词
D O I
10.1016/S0169-5002(05)80435-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S97 / S97
页数:1
相关论文
共 50 条
  • [1] Adjuvant docetaxel plus carboplatin compared with surgery only in patients with completely resected stage IB-IIIA non-small cell lung cancer: final results of CSLC201/TAX210 with Chinese Society of Lung Cancer
    Wu Yi-Long
    Yang Xue-ning
    Chen Gang
    Zhong Wen-zhao
    Ben Xiao-Song
    Gu Li-Jia
    Liao Ri-Qiang
    Yang Jin-Ji
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S583 - S584
  • [2] Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer
    Naim Younes, R.
    Gross, J. L.
    Abrao, F. C.
    Rodrigues Pereira, J.
    MINERVA CHIRURGICA, 2013, 68 (02) : 169 - 174
  • [3] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [4] Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Byun, M. K.
    Park, H. J.
    Park, H. S.
    Jeung, H.
    Cho, J. Y.
    Lee, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1982 - S1982
  • [5] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410
  • [6] Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
    Park, Hye Jung
    Park, Heae Surng
    Cha, Yoon Jin
    Lee, Sungsoo
    Jeung, Hei-Cheul
    Cho, Jae Yong
    Kim, Hyung Jung
    Byun, Min Kwang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2279 - 2287
  • [7] Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
    Lee, Kuan-Yu
    Hsu, Chen-Xiong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 647 - 648
  • [8] A phase III randomized trial of postoperative adjuvant therapy in Stage II or IIIA completely resected non-small cell lung cancer
    Yoon, S
    Choi, E
    Kim, S
    Suh, C
    Lee, J
    Shim, T
    Kim, W
    Kim, D
    Park, S
    Park, C
    LUNG CANCER, 2005, 49 : S288 - S288
  • [9] Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer
    He, Jiaxi
    Shen, Jianfei
    Yang, Chenglin
    Jiang, Long
    Liang, Wenhua
    Shi, Xiaoshun
    Xu, Xin
    He, Jianxing
    MEDICINE, 2015, 94 (22) : e903
  • [10] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Reiko Sakurai
    Yoshio Tomizawa
    Akihiro Yoshii
    Yosuke Miura
    Hiroaki Tsurumaki
    Kyoichi Kaira
    Noriaki Sunaga
    Osamu Kawashima
    Takeshi Hisada
    Masanobu Yamada
    Ryusei Saito
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 103 - 109